{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-014209","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.576289+00:00","generated_at":"2026-05-24T08:37:15.617242+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SANUWAVE posts record Q4 revenue $10.3M, FY rev $32.6M; guides 47-53% growth in FY2025","bullets":["Q4 2024 revenue $10.3M (+47% YoY); full year $32.6M (+60% YoY), both all-time records.","Gross margin improved to 77.9% (Q4) and 75.2% (FY); operating income $2.5M (Q4) and $5.4M (FY).","Adjusted EBITDA $3.7M in Q4 (vs $0.7M) and $7.2M for FY (vs -$1.2M), positive cash flow from operations.","Net loss $31.4M for FY driven by derivative liability fair value changes; capital structure simplified.","Guidance: Q1 2025 rev $8.4-9.0M (+45-55%); FY2025 rev $48-50M (+47-53%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-014209","json":"https://secwatch.observer/filing/0001628280-25-014209.json","markdown":"https://secwatch.observer/filing/0001628280-25-014209.md","text":"https://secwatch.observer/filing/0001628280-25-014209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/0001628280-25-014209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/snwv-20250321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:37:15.617242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}